The obligate intracellular development of Chlamydia suggests that the bacteria should be vulnerable to premature host cell apoptosis, but because Chlamydia-infected cells are apoptosis resistant, this has never been able to be tested. We have devised a system to circumvent the apoptotic block imposed by chlamydial infection. When the proapoptotic protein Bim S was experimentally induced, epithelial cells underwent apoptosis that was not blocked by chlamydial infection. Apoptosis during the developmental cycle prevented the generation of infectious bacteria and caused transcriptional changes of bacterial genes and loss of intracellular ATP. Intriguingly, although apoptosis resulted in destruction of host cell structures and of the Chlamydia inclusion, and prevented generation of elementary bodies, Bim S induction in the presence of a caspase inhibitor allowed differentiation into morphologically normal but noninfectious elementary bodies. These data show that chlamydial infection renders host cells apoptosis resistant at a premitochondrial step and demonstrate the consequences of premature apoptosis for development of the bacteria.
The obligate intracellular bacterium Chlamydia trachomatis is the leading cause of bacterially caused sexually transmitted disease and a major cause of preventable blindness. C. trachomatis has a well-characterized biphasic developmental cycle: the infectious elementary body (EB) infects primarily epithelial cells in vivo, where it develops within a membrane-bound vacuole, called an inclusion, into a replicating noninfectious reticulate body (RB). Despite their development in a separate intracellular compartment, chlamydiae, on one hand, acquire essential nutrients from the host cell and, on the other hand, affect various biochemical and cell signaling pathways in the host cell [1] [2] [3] .
Because C. trachomatis thus depends on the host for replication and survival, apoptosis of the host cell before the end of the developmental cycle would be expected to interrupt replication and propagation of the bacteria. In accordance with this, it has been found that all chlamydial species tested are capable of blocking experimentally induced apoptosis of the infected host cell [4 -7] . The available data indicate that apoptosis protection is limited to the mitochondrial apoptotic pathway, because host cells are not protected against apoptosis induced by death receptor ligation in cases in which a mitochondrial amplification step can be bypassed, for example, in some lymphoid cells [8] . However, epithelial cells, the natural host cells for Chlamydia, are also protected by the infection against death receptor-induced apoptosis [8] , and there is no evidence for a role of death receptor-induced apoptosis in epithelial cells during infection in vivo.
Two main signaling pathways of apoptosis have been identified, which either originate at death receptors at the cell surface or involve the release of mitochondrial proteins into the cytosol. In epithelial cells the mitochondrial pathway is more important. In this pathway, proapoptotic Bcl-2 family members are activated and cause the release of mitochondrial proteins, most notably cytochrome c [9] . According to current models, an apoptotic stimulus activates one or several of the proapoptotic class of BH3-only proteins (Bim, Puma, Noxa, Bad, and others), which then activate the effectors of cytochrome c release, Bax and Bak. Antiapoptotic proteins (Bcl-2, Bcl-x L , Bcl-w, Mcl-1, A1) inhibit this process by binding to and blocking either BH3-only proteins or Bax/Bak (see Willis et al. [10] , Kim et al. [11] , and Hacker and Weber [12] for a detailed discussion of the mechanisms).
The antiapoptotic activity of Chlamydia has been mapped to a premitochondrial effect, because the activation of Bax/Bak by apoptotic stimuli is blocked in infected cells [13, 14] . We have further reported that BH3-only proteins are degraded by a proteolytic activity in infected cells [13] , a finding that was extended and reproduced in later work [15, 16] . Because a loss of BH3-only proteins would confer protection against mitochondrial apoptotic stimuli (see, for instance, the profound effect in T cells when 2 BH3-only proteins are deleted [17] ), this could explain the profound block of apoptosis in infected cells.
However, it is possible that additional protective mechanisms exist in parallel [18] . In some but not all cells, chlamydial infection induces activity of the transcription factor family nuclear factor B (NF-B) [6, 19 -23] , and NF-B can often reduce cellular sensitivity to apoptotic stimuli [24] . Although the induction of NF-B activity is not essential for protection against apoptosis during chlamydial infection [6, 21] , it has been suggested that the NF-B-dependent transcriptional induction of the cellular protein cIAP2 can inhibit staurosporine-induced apoptosis and tumor necrosis factor-induced apoptosis by blocking effector caspase activity [25, 26] , downstream from mitochondria. These findings have yet to be reconciled with the previous observation that infection inhibits only mitochondria-dependent apoptosis.
Nonetheless, apoptosis inhibition by Chlamydia is very potent, and all stimuli tested that induce apoptosis through a mitochondrial amplification loop have been found to be countered by infection. It has thus been impossible to test the consequences of premature apoptosis in the host cell for the development and propagation of the bacteria. We have generated a cell line that allows for up-regulation of the active BH3-only protein Bim S under a tetracycline-inducible promoter. Induction of Bim S leads to mitochondrial targeting of the Bim S protein, the recruitment of Bax, and apoptosis [27] . We used this cell line in the present study with 2 objectives in mind. First, we further probed the prevalent hypotheses that Chlamydia infection blocks mitochondria-dependent apoptosis. Our previous work suggested that the degradation of BH3-only proteins is the main antiapoptotic mechanism responsible for chlamydial infection. By expressing experimentally an active BH3-only protein, we could now test this hypothesis. Second, because Bim S was found in this study to induce apoptosis even in infected cells, we were able to assess the consequences of premature apoptosis of infected cells for the development and the stress response of C. trachomatis.
MATERIALS AND METHODS

Cell lines and chlamydial organisms.
A stable T-REx-HeLa cell line (A2 clone) expressing mBim s protein was established using pcDNA 4 vectors coding for mBim s (Invitrogen), in accordance with the manufacturer's instructions, as described elsewhere [27] . A2 cells were maintained in a humidified incubator at 37°C with 5% CO 2 in Dulbecco's modified Eagle medium (PAA Laboratories) supplemented with 10% tetracycline-free fetal calf serum (PAA Laboratories), blasticidin (5 g/mL), gentamycin (50 g/mL), vancomycin (20 g/mL), and zeocin (125 g/mL). The original T-REx-HeLa cells were cultured in the same medium without zeocin. C. trachomatis strain L2 was obtained from ATCC.
Chlamydia infection and apoptosis induction. In 12-well plates 100,000 cells per well were infected with C. trachomatis at an MOI of 1-3, as described elsewhere [13, 15, 28] . Apoptosis was triggered by Bim S induction (by 1 g/mL tetracycline or 100 ng/mL anhydrotetracycline [Atc]) at 24 h after infection for 6 h, or by exposure of cells to UV irradiation (1600 J/m 2 ) in a transilluminator box (Stratagene). In some cases, zVAD-fmk (50 mol/L; Bachem) was added.
Assay for nuclear apoptosis. One hundred thousand cells per well were plated on coverslips in 12-well plates the day before Chlamydia infection. Cells were stained with 20 mol/L Hoechst 33258 (Sigma-Aldrich) for 30 min at 37°C, washed with PBS, and harvested by trypsinization. Nuclear morphological changes were determined under a fluorescence microscope. At least 300 nuclei per sample were counted.
Propagation and confocal microscopy. HeLa-T-REx or HeLa-T-REx Bim S cells (10 5 cells per well) were seeded in 12-well plates the day before infection. Cells were treated with Atc with or without zVAD-fmk after 24 h of infection. Six hours later, cells were washed with PBS and incubation was continued. After a total of 54 h of infection, cells were harvested and broken by vortexing (5 min) with glass beads. Ten percent of the cell lysate was transferred onto a fresh monolayer of HEp2 cells. One day later, HEp2 cells were fixed with 70% ethanol and stained by a fluorescein isothiocyanate-conjugated anti-Chlamydia lipopolysaccharide antibody (Progen). Inclusions were counted under a confocal microscope (Leica).
Reverse-transcriptase polymerase chain reaction (PCR).
For quantitative experiments, RNA was extracted using an RNeasy Mini Kit (Qiagen) from Chlamydia-infected Bim S HeLa-T-REx cells, treated as indicated, and reverse transcribed using TaqMan Reverse Transcription Reagents (Applied Biosystems). Quantitative PCR (qPCR) was performed with the Mx3000P system (Stratagene) using 25-L reaction volumes in Brilliant SYBR Green QPCR Master Mix (Stratagene), as described elsewhere [29] . Thermal cycling parameters were as follows: 95°C for 10 min and then 40 cycles of 95°C for 30 s, 55°C for 60 s, and 72°C for 30 s. Melting curve analysis verified prod-ucts with the expected thermal properties. Primers for chlamydial 16s rRNA were as follows: forward, 5'-TTGGGAATAACG-GTTGGAAA-3'; reverse, 5'-CCAATCTCTCAATCCGCCTA-3'. Other primer sequences are shown in table 1.
Measurement of ATP levels. The Enliten ATP assay system kit (Promega) was used to measure the ATP levels of cells, in accordance with the manufacturer's instructions (measuring luciferase activity, which correlates linearly with ATP levels). ATPwas extracted from cells with 2% trichloroacetic acid. Luciferase activity was measured in a luminometer (Berthold Detection Systems).
Electron microscopy. Cells were harvested by trypsinization and fixed in 2.5% glutaraldehyde in 0.1 mol/L sodium cacodylate buffer (pH 7.4; Electron Microscopy Sciences) and embedded in epoxy resin (Epon 812; Electron Microscopy Sciences). Ultrathin sections were examined with an EM 10 GR transmission electron microscope (Zeiss).
RESULTS
Lack of protection against Bim S -induced apoptosis.
If the apoptosis resistance of Chlamydia-infected cells were due in large part to the observed degradation of BH3-only proteins, providing an active BH3-only protein should induce apoptosis. We have obtained some evidence for this, using an assay of transient transfection of infected cells with BH3-only proteins, and we found no protection against apoptosis under these conditions [13] . However, transient transfections can cause artifacts, and it is difficult to choose the optimal time points for transfection during infection. To overcome these uncertainties, we used a cell line (designated A2) that stably carries inducible Bim S under a tetracycline-inducible promoter. (Bim S is a splice variant of Bim. We chose this variant because the more abundantly expressed Bim EL likely requires posttranslational activation [30] ). We have tested apoptosis induction by tetracycline-induced expression of Bim S and found the expected activation of the apoptotic pathway at the level of mitochondria on induction of Bim S [27] . A2 cells were infected with C. trachomatis L2, and their apoptotic response to either an extrinsic stimulus (UV light) or the tetracycline-induced expression of Bim S was monitored. As shown in figure 1A , infection protected against UV-induced apoptosis, as demonstrated elsewhere. However, there was no protection against Bim S -induced apoptosis in A2 (T-REx Bim S ) cells, while tetracycline had no effect on apoptosis or chlamydial protection in the maternal (T-REx) cell line ( figure 1A ). These results show that there is no detectable protection against apoptosis downstream of Bim S activity in infected epithelial cells.
To analyze the effects of apoptosis on chlamydial development, we modified the protocol for induction of Bim S . Instead of using tetracycline, which inhibits chlamydial infection, we used an antibiotically inactive analogue, Atc. Like tetracycline, Atc induced apoptosis in A2 cells despite chlamydial infection (figure 1B) . Addition of the caspase inhibitor zVAD-fmk blocked nuclear apoptosis (figure 1B).
Induction of apoptosis disrupts the developmental cycle of C. trachomatis. We then used this system to determine whether apoptosis might affect completion of the chlamydial developmental cycle. A2 or maternal HeLa-T-REx cells were infected with C. trachomatis. After 24 or 48 h of infection, Atc was added to induce the expression of Bim S . As shown in figure 2A , Bim S expression by Atc for 6 h induced apoptosis even at the later time points (some nuclear fragmentation was seen at 48 h with infection alone, as reported elsewhere [28] ). In some cultures, Atc was washed away 6 h after it had been added, and incubation was continued until 54 h after infection. At this point, cells were disrupted, and lysates were added directly to fresh monolayers of uninfected HEp2 epithelial cells. One day later, HEp2 cells were stained for chlamydial inclusions. Addition of Atc to T-REx cells did not alter the number of infectious EBs recovered (figure 2B shows confocal images of HEp2 cells infected with lysates, and figure 2C provides a summary of the experiments performed). When Atc was added at 24 h to infected A2 cells, the subsequent recovery of infectious bacteria was strongly reduced, whereas addition after 48 h of infection had no effect ( figure  2B, 2C) . Thus, induction of apoptosis at 24 h disrupted the development of C. trachomatis and prevented the generation of infectious EBs. Role of caspases in disruption of the developmental cycle. Many of the effects that are detectable in apoptotic cells are caused by caspase-dependent cleavage of cellular proteins. We therefore tested whether caspase-dependent degradation of host cell proteins contributed to the blockade of chlamydial development after Bim S expression. Cells were infected, as already described, and induced to undergo apoptosis with Atc, and zVAD-fmk was added to block caspases. Although zVAD-fmk was able to block the morphological signs of host cell apoptosis (figure 1B), the addition of zVAD-fmk had only a very minor effect on the number of infectious bacteria recovered (figure 3). Caspase activity therefore contributes only marginally to the disruption of the developmental cycle because of Bim S -induced apoptosis.
Effects of apoptosis on chlamydial development.
We then proceeded to analyze the effects of apoptosis on transcription of a selected set of chlamydial genes. Compared with RBs, EBs are relatively silent transcriptionally, with their condensed chromosomes bound by chlamydial histonelike proteins (hctA and hctB), though they harbor carryover transcripts of mRNA for late-cycle genes [31] . Transcript copies of chlamydial 16s rRNA are representative of the number of chlamydiae present, increasing throughout the developmental cycle, whereas transcript copies of other genes, relative to 16s rRNA, should be diminished during conversion from RBs to EBs [32] . qPCR analysis of chlamydial 16s rRNA extracted from infected host cells, with and without induction of apoptosis, indicates that the expression of 16s rRNA in chlamydiae in apoptotic host cells decreases 5-fold, compared with chlamydiae in viable cells, and this decrease could be only partially rescued by inhibition of caspases (figure 4). In contrast, several chlamydial genes involved in stress responses, bacterial division, or conversion of RBs to EBs were more transcriptionally active in chlamydiae in dying host cells than in untreated host cells (table 1) . Relative expression was found to be increased for late genes involved in initiating chromosome condensation (hctA) and cell division (ftsW), as well as for a midcycle gene involved in fusing inclusion membranes (incA) and a consistently expressed molecular chaperone (dnaK) [31, 33] (table 1) , despite the lower number of 16s rRNA copies (figure 4). These results suggest that development was incomplete and more RBs would be represented in the diminished chlamydial population in dying cells. Alternatively, given the high level of condensation of EB chromosomes, downregulation of RB transcripts may be incomplete before differentiation of RBs into EBs in dying host cells.
Depletion of ATP in infected and uninfected cells undergoing apoptosis. Chlamydia probably depend at least to some extent on host cell-produced ATP for their development [34 -36] . Induction of apoptosis in infected cells by Bim S caused a drop in cellular ATP levels and this drop was not prevented by caspase inhibition (figure 5). It is therefore possible that impairment of mitochondrial function by Bim S and subsequent reduction of host cell ATP levels are factors that affect chlamydial development.
Ultrastructure of Chlamydiae and the chlamydial inclusion on induction of apoptosis. RBs and EBs can be differentiated by electron microscopy. At 24 h after we infected A2 cells, we induced apoptosis by Atc for 6 h, in the presence or absence of the caspase inhibitor. We then analyzed the cells 54 h after infection.
zVAD-fmk had no detectable effect on the development of the chlamydial inclusion or the differentiation of bacteria (figure 6). Induction of Bim S caused massive morphological changes in the host cell, breakdown of inclusions, and the release of chlamydial RBs into the culture. Where inclusions were preserved, the redifferentiation of RBs to EBs was greatly reduced (figure 6; data not shown). Where Bim S induction was accompanied by caspase inhibition, host cell morphology was by and large conserved. Intriguingly, RBs were able to develop into morphologically typical EBs in normal numbers under these conditions, although the EBs recovered were not infectious (see above). Counting EBs and RBs showed no substantial differences between cells treated with Atc and zVAD-fmk and cells treated with zVAD-fmk alone (not shown). The only difference that could be observed was that in approximately half of the cells treated with both Atc and zVAD-fmk there was a noticeable gap between the bacterial population and the inclusion membrane (figure 6), a feature that is not normally seen during infection. Apart from this difference, there was no ultrastructural basis for the lack of infectivity of EBs recovered from apoptotic cells whose caspases had been inhibited. Induction of apoptosis thus blocks chlamydial development at 2 levels. First, caspase activation destroys the host cell and prevents completion of the chlamydial development cycle. Second, host cell apoptosis also blocks generation of infectious EBs even when caspases are inhibited, possibly owing to a lack of ATP (and perhaps other nutrients) caused by Bim S -induced mitochondrial destabilization. Although the latter mechanism allows RBs to differentiate into bacteria with morphological features of EBs, the EBs are noninfectious.
DISCUSSION
We have demonstrated elsewhere [13, 15] that the members of the essential class of proapoptotic BH3-only proteins are degraded during chlamydial infection, suggesting this may be a reason for protection by Chlamydia. By demonstrating that infected cells are not protected against the active BH3-only protein Bim S , we here establish that the apoptotic defect during infection is indeed the generation of active BH3-only proteins, which corroborates our previous hypothesis. Bim S -induced mitochondrial apoptosis interfered with chlamydial development in 2 ways: first, through caspase-mediated destruction of cellular substrates and, second, through a caspase-independent mechanism that likely involves loss of cellular ATP, presumably as the result of mitochondrial damage. Intriguingly, the latter mechanism still allowed the emergence of morphologically normal EBs that were, however, noninfectious. Human cells have thus at least 2 apoptosis-related mechanisms to defend themselves against infection. Furthermore, our results suggest that specific targeting of the apoptotic blockade might be a viable future approach to treat chronic chlamydial infections.
There is no agreement yet on how Chlamydia inhibits apoptosis. The 2 main competing proposals are that host cells are resistant to externally induced apoptosis owing to the loss of BH3-only proteins or the up-regulation of cIAP2, which has been observed in some cells. Some members of the inhibitors of apo- ptosis (IAP) family of proteins can inhibit active effector caspases, although this is doubtful for cIAP2 [37] , and it has been proposed that cIAP2, perhaps in a complex with other IAP, can therefore inhibit postmitochondrial events during apoptosis [25, 26] . Recent data, however, strongly suggest that the function of cIAPs is not in postmitochondrial caspase inhibition but in regulating NF-kB signaling [38, 39] . Our results address this issue further in 2 ways. First, because there was no detectable protection against Bim S -induced apoptosis, the possible upregulation of cIAP2 is unlikely to be of general importance for (postmitochondrial) apoptosis inhibition by Chlamydia. Second, the inhibition of caspases during apoptosis induction in infected cells failed to rescue infectivity of EBs. Thus, even if cIAP2, or another IAP, were up-regulated and able to block caspases, this mechanism of host cell resistance against apoptosis would not be effective in rescuing infectivity of chlamydiae. Our data therefore support the hypothesis that the degradation of BH3-only proteins is the main mechanism of apoptosis inhibition by Chlamydia.
It is noteworthy that apoptosis induced after 48 h of infection had no effect on infectivity, suggesting that mature EBs are resilient to the proteolytic activity of caspases and their infectivity is not affected by caspase proteolysis. The structurally normal redifferentiation of chlamydiae into EBs in apoptotic cells whose caspases were inhibited was surprising, and it is unclear which nutrient, besides host cell ATP, may be lacking to prevent the EBs from becoming infectious. The only structural change observed was that the chlamydial population seemed to have lost direct contact with the inclusion membrane in a substantial fraction of the cells. Detachment of RBs from the inclusion membrane has been proposed as a trigger for differentiation into EBs [40] . Thus, changes in inclusion membrane composition and physiology could induce subtle changes that support the transformation of RBs into only noninfectious EBs.
In summary, our data show that apoptosis, if initiated halfway through the chlamydial developmental cycle, could be an effec- Figure 5 . Intracellular ATP levels in Chlamydia-infected cells during apoptosis induced by Bim S . HeLa-T-REx Bim S cells were infected with Chlamydia trachomatis for 24 h, followed by treatment with anhydrotetracycline (Atc), zVAD-fmk, or both for 6 h. Cells were harvested for extraction of intracellular ATP, and ATP levels were measured, as described in Materials and Methods. After measurement of ATP levels, the ATP concentration was normalized, with the value for untreated cells set to 1. Data are means Ϯ SEMs of 3 independent experiments. Figure 6 . Ultrastructure of chlamydiae on induction of Bim S . HeLa-T-REx Bim S cells were infected with Chlamydia trachomatis for 24 h at an MOI of 1-3, followed by treatment with anhydrotetracycline (Atc) (Bim S ), zVAD-fmk, or both for 6 h. Cells were then washed with PBS and placed back into culture until 54 h after infection. Ultrastructure was determined by electron microscopy. Typical features of each condition are shown. Bottom right panel, in a number of cells (ϳ50%) treated with Atc to induce Bim S plus zVAD-fmk to inhibit caspases, an unusual separation of bacteria from the inclusion membrane was observed (arrows). Top right panel, a cell treated with zVAD-fmk alone is shown for comparison.
tive host defense mechanism against chlamydial infection. Conferring an antiapoptotic activity on the host cell, therefore, makes a lot of sense for the bacteria. It is still unclear what apoptotic stimulus makes the activity necessary, but the infected cell most likely detects the presence of intracellular Chlamydia through pattern recognition receptors, and one effect of this recognition may be the induction of apoptosis [41] . Other obligate intracellular bacteria, such as Rickettsia, also protect their host cells against apoptosis [42] , suggesting that resistance against premature host cell apoptosis may be a general strategy required for infection by other obligate intracellular pathogens. Conversely, these intracellular bacteria might all be vulnerable to functional restoration of the apoptotic apparatus. Although acute infections by Chlamydia are easily treated with antibiotics, chronic chlamydial infections can have very serious consequences, and in vitro evidence suggests that antibiotic treatment alone is insufficient to eradicate the bacteria and may even facilitate their persistence [43] . New strategies for therapeutic apoptosis induction in human cells are being pursued intensively at present, largely for cancer treatment. Notable examples are the Bcl-2 inhibitors, of which the compound ABT-737 is being successfully employed in mouse models to induce tumor regression [44] . It will also be worth considering such approaches for the treatment of chronic chlamydial diseases.
